Neurizon Therapeutics Limited

Neurizon Therapeutics Limited

NUZ.AX
Neurizon Therapeutics LimitedAU flagAustralian Securities Exchange
0.07
AUD
+0.00
- -
54.98MMarket Cap

Total Valuation

Neurizon Therapeutics Limited carries a market capitalization of 54.98M, placing it among publicly traded companies globally.

Market Cap54.98M
Enterprise ValueN/A

Stock Price Statistics

Neurizon Therapeutics Limited's stock has declined approximately -53.54839% over the past 52 weeks. The 50-day moving average sits at 0.07, while the 200-day moving average is 0.09.

Beta (5Y)N/A
52-Week Price Change-53.54839%
50-Day Moving Average0.07
200-Day Moving Average0.09
Average Volume (20 Days)N/A

Stock Splits

Neurizon Therapeutics Limited's most recent stock split took place on February 20, 2019 with a 500:551 split ratio.

Last Split Date2/20/2019
Split Ratio500:551